MICRODOSE THERAPEUTX, INC. Patent applications |
Patent application number | Title | Published |
20150209328 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus. | 07-30-2015 |
20140261414 | INHALATION DEVICE, CONTROL METHOD AND COMPUTER PROGRAM - The invention provides an inhalation device using an electrically driven vibratory element for releasing a drug dose into a flow channel, and a controller for activating/deactivating the vibratory element. A sensor arrangement is able to differentiate between inhalation flow and exhalation flow through the flow channel, to assist in forming a model of the breathing pattern of the user. The device can detect reliably inhalation flow patterns from patients of all ages. | 09-18-2014 |
20140154323 | METHOD FOR TREATING BRONCHIAL DISEASES - Administration of a loop diuretic in nebulized dry powder form directly to a patient's lungs for treating bronchial disease. | 06-05-2014 |
20140072532 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infection. | 03-13-2014 |
20140041659 | INHALATION DEVICE AND METHOD - The present disclosure provides a method and device for delivering a pharmaceutical to the airway of a human or animal patient. In one aspect, the device includes a dose drum formed into a cylinder and including a plurality of dose compartments for containing individual doses. In another aspect, the device may include a reservoir containing a pharmaceutical material in bulk form and a metering recess for metering the pharmaceutical material to form a pharmaceutical dose. Another aspect provides an inhaler with a combined reservoir and dosing chamber configured to contain multiple doses of a pharmaceutical material. | 02-13-2014 |
20140038912 | ADENOSINE ANALOGS AND THEIR USE - Provided are adenosine analog compounds of the general formula that act as P2Y receptors, e.g., the P2Y | 02-06-2014 |
20130267593 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - Administration of Oxybutynin directly to a patient's lungs for treating urinary incontinence, respiratory disease or IBD. | 10-10-2013 |
20130228175 | INHALATION DEVICE - A dry inhaler system includes a vibrating mechanism. A supply of a dry powder is operatively coupled to the vibrating mechanism. A power source communicates with the vibrating mechanism. A sensor communicates with the vibrating mechanism. A feedback control communicates with the sensor and the power source. The feedback control controls power delivered to the vibrating mechanism relative to information provided by the sensor about the performance of the vibrating mechanism. | 09-05-2013 |
20130213392 | METHOD AND DEVICE FOR CLAMPING A BLISTER WITHIN A DRY POWDER INHALER - The present disclosure provides an inhaler having a vibration element for aerosolizing medicament contained in a blister pack, wherein individual blister packs are positioned within the housing to be simultaneously engaged with the flow channel and the vibration element. The flow channel includes a blister pack clamping surface that engages the blister pack near the top of the crown and allows the blister three rotational degrees of freedom. The advantages of this arrangement include improved consistency and higher airspeed of the synthetic jet, as well as other advantages. | 08-22-2013 |
20130189319 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - The present invention is directed to methods and compositions for treating pulmonary disease comprising delivering directly to a patient's lungs a therapeutically effective amount of oxybutynin in combination with one or more pharmaceutically effective agents. Oxybutynin may be selected from the group consisting of, but not limited to, a xinafoate salt, a palmitate salt, a pamoic salt, a resonate salt, a laurate salt and other salts. The pharmaceutically effective agents comprise bronchodilators, antiinflammatories, corticosteroids, corticosteroid reversal agent or alveolar growth agents or other agents selected from proteinase or protease inhibitors. | 07-25-2013 |